Pathogen-reduced Ebola virus convalescent plasma: first steps towards standardization of manufacturing and quality control including assessment of Ebola-specific neutralizing antibodies. - Geisen, C.; Kann, G.; Strecker, T.; Wolf, T.; Schüttfort, G.; Kraaij, M.; MacLennan, S.; Rummler, S.; Weinigel, C.; Eickmann, M.; Fehling, S. K.; Krähling, V.; et al. (Vox Sanguinis, 2016)